A detailed history of Thompson Davis & Co., Inc. transactions in Profound Medical Corp. stock. As of the latest transaction made, Thompson Davis & Co., Inc. holds 74,800 shares of PROF stock, worth $557,260. This represents 0.56% of its overall portfolio holdings.

Number of Shares
74,800
Previous 68,650 8.96%
Holding current value
$557,260
Previous $585,000 7.18%
% of portfolio
0.56%
Previous 0.4%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$7.25 - $9.07 $44,587 - $55,780
6,150 Added 8.96%
74,800 $627,000
Q1 2024

May 02, 2024

BUY
$7.3 - $9.46 $1,642 - $2,128
225 Added 0.33%
68,650 $585,000
Q4 2023

Feb 05, 2024

SELL
$7.85 - $11.18 $140,907 - $200,681
-17,950 Reduced 20.78%
68,425 $580,000
Q3 2023

Nov 09, 2023

SELL
$7.91 - $13.27 $751 - $1,260
-95 Reduced 0.11%
86,375 $881,000
Q2 2023

Jul 13, 2023

BUY
$9.27 - $14.88 $100,811 - $161,820
10,875 Added 14.39%
86,470 $1.12 Million
Q1 2023

May 09, 2023

BUY
$8.85 - $13.27 $38,055 - $57,061
4,300 Added 6.03%
75,595 $702,000
Q4 2022

Feb 06, 2023

BUY
$3.18 - $10.91 $161,254 - $553,235
50,709 Added 246.33%
71,295 $776,000
Q3 2022

Nov 09, 2022

SELL
$3.99 - $9.3 $15,265 - $35,581
-3,826 Reduced 15.67%
20,586 $83,000
Q2 2022

Aug 04, 2022

SELL
$6.34 - $9.53 $340,267 - $511,475
-53,670 Reduced 68.74%
24,412 $178,000
Q2 2022

Aug 02, 2022

BUY
$6.34 - $9.53 $294,068 - $442,029
46,383 Added 146.32%
78,082 $569,000
Q1 2022

May 13, 2022

SELL
$8.16 - $11.33 $11,742 - $16,303
-1,439 Reduced 4.34%
31,699 $285,000
Q4 2021

Feb 14, 2022

BUY
$10.38 - $15.2 $343,972 - $503,697
33,138 New
33,138 $374,000

Others Institutions Holding PROF

About Profound Medical Corp.


  • Ticker PROF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,851,300
  • Market Cap $155M
  • Description
  • Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...
More about PROF
Track This Portfolio

Track Thompson Davis & Co., Inc. Portfolio

Follow Thompson Davis & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thompson Davis & Co., Inc. with notifications on news.